论文部分内容阅读
目的:探讨未足月胎膜早破残余羊水量对孕妇分娩方式及母婴结局的影响。方法:选取2015年1月至2016年6月于潮州中心医院住院分娩的90例未足月胎膜早破产妇作为研究对象,按照胎膜早破后羊水指数(AFI)进行分组,8 cm≤AFI<25 cm为正常组,5 cm≤AFI<8 cm为羊水偏少组,AFI<5 cm为羊水极少组,每组各30例。三组均予以常规检查、抗感染治疗,记录三组产妇的分娩方式与母婴结局,并进行对比分析。结果:羊水正常组自然分娩率显著高于其他两组,差异有统计学意义(P<0.05);三组产后出血、胎盘早剥、新生儿窒息、低血糖、先天性感染、呼吸性酸中毒等发生情况相比,差异无统计学意义(P>0.05);而三组羊膜腔感染、新生儿肺炎、新生儿黄疸相比,差异有统计学意义(P<0.05),且均是羊水极少组发生率最高。结论:早期未足月胎膜早破残余羊水量可作为评估母婴情况的重要指标,当AFI<5 cm时感染率与剖宫产率均较高,促胎肺成熟治疗后尽早终止妊娠,妊娠后加强临床监测,以改善母婴预后。
Objective: To investigate the influence of residual amniotic fluid in premature rupture of membranes on the mode of delivery and maternal and infant outcomes of pregnant women. Methods: From January 2015 to June 2016, 90 under-term premature rupture of membranes of premature rupture of membranes in hospital of Chaozhou Central Hospital were enrolled in this study. According to amniotic fluid index (AFI) after premature rupture of membranes, 8 cm≤ AFI <25 cm for the normal group, 5 cm≤AFI <8 cm for oligohydramnios group, AFI <5 cm for the very few groups of amniotic fluid, 30 cases for each group. All three groups were routinely checked and anti-infective therapy. The maternal delivery mode and maternal-infant outcome were recorded in three groups and analyzed comparatively. Results: The natural delivery rate of normal amniotic fluid group was significantly higher than that of the other two groups (P <0.05). The postpartum hemorrhage, placental abruption, neonatal asphyxia, hypoglycemia, congenital infection, respiratory acidosis (P> 0.05). However, there were significant differences between the three groups in amniotic cavity infection, neonatal pneumonia and neonatal jaundice (P <0.05), and all were amniotic fluid pole The highest incidence of less groups. CONCLUSION: The residual amniotic fluid volume of preterm premature rupture of membranes can be used as an important index in assessing maternal and neonatal conditions. When the AFI is less than 5 cm, the infection rate and cesarean section rate are both high, and the pregnancy is terminated as soon as possible after fetal lung maturation. Strengthen the clinical monitoring after pregnancy to improve maternal and child prognosis.